RNXT
Income statement / Annual
Last year (2023), RenovoRx, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, RenovoRx, Inc.'s net income was -$10.23 M.
See RenovoRx, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$6,000.00 |
$9,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
-$6,000.00 |
-$9,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.67 M
|
$4.30 M
|
$3.04 M
|
$2.39 M
|
$3.00 M
|
| General & Administrative
Expenses |
$5.73 M
|
$5.65 M
|
$2.63 M
|
$818,000.00
|
$899,000.00
|
| Selling & Marketing
Expenses |
$5.72 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.73 M
|
$5.65 M
|
$2.63 M
|
$818,000.00
|
$899,000.00
|
| Other Expenses |
$0.00 |
$61,000.00 |
$119,000.00 |
-$7,000.00 |
$2,000.00 |
| Operating Expenses |
$11.40 M |
$9.95 M |
$5.67 M |
$3.20 M |
$3.90 M |
| Cost And Expenses |
$11.40 M |
$9.95 M |
$5.67 M |
$3.20 M |
$3.90 M |
| Interest Income |
$0.00 |
$57,000.00 |
$70,000.00 |
$3,000.00 |
$63,000.00 |
| Interest Expense |
$108,000.00 |
$57,000.00 |
-$834,000.00 |
$590,000.00 |
$0.00 |
| Depreciation &
Amortization |
$6,000.00
|
$6,000.00
|
$9,000.00
|
$3.20 M
|
$3.90 M
|
| EBITDA |
-$11.39 M
|
-$9.95 M
|
-$5.72 M
|
-$3.21 M
|
-$3.83 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.16 M
|
$61,000.00
|
-$653,000.00
|
-$594,000.00
|
$57,000.00
|
| Income Before Tax |
-$10.23 M |
-$9.89 M |
-$6.32 M |
-$3.80 M |
-$3.84 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$6.00 |
-$118,000.00 |
$772,000.00 |
$587,000.00 |
-$63,000.00 |
| Net Income |
-$10.23 M |
-$9.77 M |
-$7.10 M |
-$4.39 M |
-$3.78 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.99 |
-1.08 |
-0.79 |
-0.51 |
-0.44 |
| EPS Diluted |
-0.99 |
-1.08 |
-0.79 |
-0.51 |
-0.44 |
| Weighted Average Shares
Out |
$10.29 M
|
$9.05 M
|
$8.93 M
|
$8.66 M
|
$8.66 M
|
| Weighted Average Shares
Out Diluted |
$10.29 M
|
$9.05 M
|
$8.93 M
|
$8.66 M
|
$8.66 M
|
| Link |
|
|
|
|
|
